Karen and Michael Hubbard therefore failed to link Bayer’s allegedly inadequate warning to Karen Hubbard’s injury, the U.S. Court of Appeals for the Eleventh Circuit said. Under Georgia’s learned intermediary principle, a drugmaker’s duty to warn runs to the physician.
Hubbard had been taking Beyaz for a little less than a year when she suffered a ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.